Post-infarct ventricular septal rupture: early Impella implantation to delay surgery and reduce surgical risk

被引：20

作者：

Ancona M.B. ^{[1
]}

Regazzoli D. ^{[1
]}

Mangieri A. ^{[1
]}

Monaco F. ^{[2
]}

De Bonis M. ^{[3
]}

Latib A. ^{[1
,4
]}

机构：

[1] Interventional Cardiology Unit, San Raffaele Scientific Institute, 60 Via Olgettina, Milan

[2] Anesthesia and Intensive Care Department, San Raffaele Scientific Institute, Milan

[3] Cardiac Surgery Unit, San Raffaele Scientific Institute, Milan

[4] Interventional Cardiology Unit, EMO-GVM Centro Cuore Columbus, Milan

来源：

Cardiovascular Intervention and Therapeutics | 2017年 / 32卷 / 4期

关键词：

Left ventricular assistance device; Surgical repair; Ventricular septal rupture;

D O I：

10.1007/s12928-016-0428-7

中图分类号：

学科分类号：

摘要：

Ventricular septal rupture (VSR) is a complication of myocardial infarction. Surgery is the only treatment; however, mortality is high, especially if it is performed within 7 days from presentation. The improved outcome with delayed intervention could be related to evolution of the infarct, which allows a more effective surgical repair. However, it is also a representation of survival bias, as an early surgery is usually performed on individuals with hemodynamic instability. We present a case of VSR complicated by cardiogenic shock. An early hemodynamic stabilization was achieved with Impella implantation; the delay in surgery allowed a reduction in surgical risk. © 2016, Japanese Association of Cardiovascular Intervention and Therapeutics.

引用

页码：381 / 385

页数：4

共 7 条

[1] Jones B.M., Kapadia S.R., Smedira N.G., Robich M., Tuzcu E.M., Venon M., Et al., Ventricular septal rupture complicating acute myocardial infarction: a contemporary review, Eur Heart J, 35, pp. 2060-2068, (2014)
[2] Crenshaw B.S., Granger C.B., Birnbaum Y., Pieper K.S., Morris D.C., Kleiman N.S., Et al., Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators, Circulation, 101, pp. 27-32, (2000)
[3] Arnaoutakis G.J., Zhao Y., George T.J., Sciortino C.M., McCarthy P.M., Conte V.J., Surgical repair of ventricular septal defect after myocardial infarction: outcomes from the Society of Thoracic Surgeons National Database, Ann Thorac Surg, 94, pp. 436-443, (2012)
[4] Windecker S., Kolh P., Alfonso F., Collet J.P., Cremer J., Falk V., Et al., ESC/EACTS Guidelines on myocardial revascularization, Eur Heart J, 35, pp. 2541-2619, (2014)
[5] La Torre M.W., Centofanti P., Attisani M., Patane F., Rinaldi M., Posterior ventricular septal defect in presence of cardiogenic shock. Early implantation of the Impella recover LP 5.0 as a bridge to surgery, Tex Heart Inst J, 38, pp. 42-49, (2011)
[6] Rihal C.S., Naidu S.S., Givertz M.M., Szeto W.Y., Burke J.A., Kapur N.K., Et al., SCAI/ACC/HFSA/STS Clinical Expert Consensus Statement on the Use of Percutaneous Mechanical Circulatory Support Devices in Cardiovascular Care (Endorsed by the American Heart Association, the Cardiological Society of India, and Sociedad Latino Americana de Cardiologia Intervencion
[7] Affirmation of Value by the Canadian Association of Interventional Cardiology-Association Canadienne de Cardiologie d’intervention), J Am Coll Cardiol, 65, pp. e7-e26, (2015)

← 1 →